米国の乳房温存手術市場規模、シェア、動向分析レポート：手技別、製品別、最終用途別、セグメント別予測、2025～2033年

市場規模と動向

米国の乳房温存手術市場規模は2024年に7億4,432万米ドルと推定され、2025～2033年にかけてCAGR 7.18％で成長すると予測されています。

市場成長の背景には、マンモグラフィ検診プログラムの普及や患者の意識向上キャンペーンに支えられた早期乳がんの有病率の上昇があります。こうした取り組みにより早期発見率が上昇し、乳腺腫瘤摘出術や四分割切除術のような乳房温存手術の対象となる患者が増加しています。さらに、特に若い患者の間では、乳房の外観と機能を温存する手術が強く望まれており、これは乳房温存手術（BCS）の原則と一致しています。

外来手術施設の成長は米国市場の主要促進要因であり、入院患者の手術に代わる費用対効果が高く患者に優しい選択肢を提供しています。このような施設は、先進的手術技術、経験豊富なスタッフ、合理化されたプロセスを備えつつあり、一般的に侵襲が少なく回復時間が短いBCSのような手術に適しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の乳房温存手術市場の変数、動向、範囲

• 市場系統の展望
  • 関連/補助的な市場展望
• ユーザーの視点分析
  • 消費者行動分析
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 米国の乳房温存手術市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国の乳房温存手術市場：手技別、推定・動向分析

• セグメントダッシュボード
• 米国の乳房温存手術市場：手技変動分析と市場シェア、2024年と2033年
• 乳房切除術
• 四分円切除術
• 部分乳房切除術

第5章 米国の乳房温存手術市場：製品別、推定・動向分析

• セグメントダッシュボード
• 米国の乳房温存手術市場：製品変動分析と市場シェア、2024年と2033年
• 腫瘍局在化デバイス
  • ワイヤガイドによる位置特定
  • 磁気シードの位置特定
  • レーダーベース位置特定
  • その他
• 外科的切除デバイス
  • 電気外科ユニット/デバイス
  • メス/鉗子/開創器/クランプ
  • 真空アシスト生検システム
  • その他
• マージン評価デバイス
• 術中画像とナビゲーションデバイス

第6章 米国の乳房温存手術市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 米国の乳房温存手術市場：最終用途変動分析と市場シェア、2024年と2033年
• 病院
• 外来手術センター
• 腫瘍学/専門クリニック
• その他

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
  • イノベーター
• ベンダー情勢
  • 主要販売代理店とチャネルパートナー一覧
  • 主要企業の市場シェア分析、2024年
  • Hologic, Inc
  • Argon Medical Devices
  • Merit Medical Systems
  • KUBTEC
  • Stryker
  • Mammotome（Danaher）
  • CairnSurgical Inc.
  • Lumicell Inc
  • Innoblative Designs
  • Perimeter Medical Imaging AI

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. breast conserving surgery market, by procedure, 2021 - 2033 (USD Million)
• Table 4 U.S. breast conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 5 U.S. breast conserving surgery market, by end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Breast conserving surgery market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2024)
• Fig. 10 Segment outlook
• Fig. 11 Strategy framework
• Fig. 12 Penetration & growth prospect mapping
• Fig. 13 Consumer behavior analysis
• Fig. 14 Market driver relevance analysis (Current & future impact)
• Fig. 15 Market restraint relevance analysis (Current & future impact)
• Fig. 16 Porter's Five Forces analysis
• Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 18 Lumpectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 19 Quadrantectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 20 Segmental mastectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 21 Tumor localization devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 22 Wire-guided localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 23 Magnetic seed localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 24 Radar-based localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 25 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 26 Surgical excision devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 27 Electrosurgical units/devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 28 Scalpels/forceps/retractors/clamps market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 29 Vacuum-assisted biopsy systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 30 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 31 Margin assessment devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 32 Intraoperative imaging & navigation devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 33 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 34 Ambulatory surgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 35 Oncology/specialty clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 36 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 37 Company market share analysis, 2024
• Fig. 38 Market differentiators

Market Size & Trends:

The U.S. breast conserving surgery market size was estimated at USD 744.32 million in 2024 and is projected to grow at a CAGR of 7.18% from 2025 to 2033. The market growth is attributed to the rising prevalence of early-stage breast cancer, supported by widespread mammography screening programs and patient awareness campaigns. These initiatives have led to an increase in early detection rates, making more patients eligible for breast-conserving procedures like lumpectomy and quadrantectomy. In addition, there is a strong preference for procedures that preserve breast appearance and function, especially among younger patients, which aligns with the principles of breast conserving surgery (BCS).

The growth of ambulatory surgical settings is a key driver of the U.S. market, offering a cost-effective, patient-friendly alternative to inpatient hospital procedures. These settings are increasingly equipped with advanced surgical technologies, experienced staff, and streamlined processes that make them well suited for procedures like BCS, which are typically less invasive and have shorter recovery times.

U.S. Breast Conserving Surgery Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. breast conserving surgery market report based on procedure, product, and end use:

• Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Lumpectomy
• Quadrantectomy
• Segmental Mastectomy
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Tumor Localization Devices
  • Wire-guided localization
  • Magnetic seed localization
  • Radar-based localization
  • Others
• Surgical Excision Devices
  • Electrosurgical units/devices
  • Scalpels/forceps/retractors/clamps
  • Vacuum-assisted biopsy systems
  • Others
• Margin Assessment Devices
• Intraoperative Imaging & Navigation Devices
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Centers
• Oncology/Specialty Clinics
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Third Party Perspective
  • 1.3.5. Primary research
  • 1.3.6. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights Outlook

Chapter 3. U.S. Breast Conserving Surgery Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Related/ancillary market outlook.
• 3.2. User Perspective Analysis
  • 3.2.1. Consumer behavior analysis
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1. Increasing breast cancer incidence and focus on early detection
    • 3.3.1.2. Rising preference for cosmetic and functional preservation
    • 3.3.1.3. Technological advancement in wireless localization and AI-based margin assessment
    • 3.3.1.4. Growth of ambulatory surgical settings
    • 3.3.1.5. Favorable government and reimbursement support in developed nations
  • 3.3.2. Market restraint analysis
    • 3.3.2.1. High cost of advanced technologies
    • 3.3.2.2. Limited access to early diagnosis
  • 3.3.3. Market opportunity analysis
    • 3.3.3.1. Shift toward outpatient & minimally invasive procedures
  • 3.3.4. Market challenge analysis
    • 3.3.4.1. Reoperation risk due to positive margins
• 3.4. U.S. Breast Conserving Surgery Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. U.S. Breast Conserving Surgery Market: Procedure Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Breast Conserving Surgery Market: Procedure Movement Analysis & Market Share, 2024 & 2033
• 4.3. Lumpectomy
  • 4.3.1. Lumpectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Quadrantectomy
  • 4.4.1. Quadrantectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Segmental Mastectomy
  • 4.5.1. Segmental Mastectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Breast Conserving Surgery Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Breast Conserving Surgery Market: Product Movement Analysis & Market Share, 2024 & 2033
• 5.3. Tumor Localization Devices
  • 5.3.1. Tumor Localization Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. Wire-Guided Localization
    • 5.3.2.1. Wire-guided localization market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.3.3. Magnetic Seed Localization
    • 5.3.3.1. Magnetic seed localization market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.3.4. Radar-Based Localization
    • 5.3.4.1. Radar-based localization market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.3.5. Others
    • 5.3.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
• 5.4. Surgical Excision Devices
  • 5.4.1. Surgical Excision Devices Market Estimates And Forecasts 2021 to 2033 (USD Million)
  • 5.4.2. Electrosurgical Units/Devices
    • 5.4.2.1. Electrosurgical units/devices market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.3. Scalpels/Forceps/Retractors/Clamps
    • 5.4.3.1. Scalpels/forceps/retractors/clamps market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.4. Vacuum-Assisted Biopsy Systems
    • 5.4.4.1. Vacuum-assisted biopsy systems market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.5. Other
    • 5.4.5.1. Other market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Margin Assessment Devices
  • 5.5.1. Margin Assessment Devices Market Estimates And Forecasts 2021 to 2033 (USD Million)
• 5.6. Intraoperative Imaging & Navigation Devices
  • 5.6.1. Intraoperative Imaging & Navigation Devices Market Estimates And Forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Breast Conserving Surgery Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Breast Conserving Surgery Market: End Use Movement Analysis & Market Share, 2024 & 2033
• 6.3. Hospitals
  • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Ambulatory Surgery Centers
  • 6.4.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Oncology/Specialty Clinics
  • 6.5.1. Oncology/Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
  • 7.2.1. Innovators
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2024
  • 7.3.4. Hologic, Inc
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Argon Medical Devices
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Merit Medical Systems
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. KUBTEC
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Stryker
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Mammotome (Danaher)
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. CairnSurgical Inc.
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Lumicell Inc
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Innoblative Designs
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Perimeter Medical Imaging AI
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives